SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 101 filers reported holding SPERO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $22,701 | -83.4% | 15,656 | -91.6% | 0.00% | – |
| Q2 2022 | $137,000 | -42.9% | 185,751 | +573.1% | 0.00% | – |
| Q1 2022 | $240,000 | -65.2% | 27,597 | -35.8% | 0.00% | – |
| Q4 2021 | $689,000 | -40.4% | 43,000 | -31.5% | 0.00% | – |
| Q3 2021 | $1,156,000 | +8.6% | 62,800 | -17.6% | 0.00% | – |
| Q2 2021 | $1,064,000 | -22.6% | 76,212 | -18.4% | 0.00% | – |
| Q1 2021 | $1,375,000 | -44.7% | 93,380 | -27.1% | 0.00% | – |
| Q4 2020 | $2,485,000 | +242.3% | 128,138 | +97.1% | 0.00% | – |
| Q3 2020 | $726,000 | – | 65,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,353,303 | $1,637,497 | 13.93% |
| Anson Funds Management LP | 4,159,572 | $5,033,082 | 1.01% |
| OUP Management Co., LLC | 249,070 | $301,375 | 0.68% |
| Atlas Venture Life Science Advisors, LLC | 1,013,438 | $1,226,260 | 0.19% |
| Murchinson Ltd. | 862,700 | $1,043,867 | 0.13% |
| Alphabet Inc. | 889,979 | $1,076,874 | 0.07% |
| AWM Investment Company, Inc. | 333,400 | $403,414 | 0.06% |
| DAFNA Capital Management LLC | 125,000 | $151,250 | 0.05% |
| Novo Holdings A/S | 468,902 | $567,371 | 0.04% |
| XTX Topco Ltd | 58,368 | $70,625 | 0.01% |